⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRL News
Charles River Laboratories International, Inc.
Patient-Derived Xenograft/PDX Model Market worth US$0.66 billion by 2030 with 12.5% CAGR | MarketsandMarkets™
prnewswire.com
CRL
JAX
WUX
INVT
HBLA
Genomics Market worth $85.09 billion by 2030 with 12.6% CAGR | MarketsandMarkets™
prnewswire.com
ILMN
TMO
DHR
AGNC
PACB
NVTA
ABT
LH
IQV
CRL
BIIB
BDX
REV
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
businesswire.com
CRL
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
prnewswire.com
CRL
Charles River Laboratories Provides Update on Strategic Review
businesswire.com
CRL
Charles River Laboratories Announces Third-Quarter 2025 Results
businesswire.com
CRL
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
prnewswire.com
CRL
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
businesswire.com
CRL
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
businesswire.com
CRL
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
businesswire.com
CRL